<p>Immune Checkpoint Inhibitor Therapy Achieved Complete Response for Drug-Sensitive<em> EGFR/ALK</em> Mutation-Negative Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma with High Tumor Mutation Burden: A Case Report</p>-Reference-Cited by-同舟云学术

Immune Checkpoint Inhibitor Therapy Achieved Complete Response for Drug-Sensitive EGFR/ALK Mutation-Negative Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma with High Tumor Mutation Burden: A Case Report

Published:2020-08 Issue: Volume:Volume 13 Page:8245-8250
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Zhang Xin,Sun Yanbin^ORCID,Miao Yuan^ORCID,Xu Shun

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference24 articles.

1. Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy

2. Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung

3. Role of Chemotherapy and the Receptor Tyrosine Kinases KIT, PDGFRα, PDGFRβ, and Met in Large-Cell Neuroendocrine Carcinoma of the Lung

4. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy

5. Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report;The Clinical Respiratory Journal;2024-09

2. Efficacy and safety of immune checkpoint inhibitors in lung large-cell neuroendocrine carcinoma;Journal of Thoracic Disease;2023-08

3. Neuroendocrine Tumors and Immune System;Interdisciplinary Cancer Research;2023

4. A multiple detection method for distinguishing gene mutations based on melting curves of extended quenching probes;Heliyon;2022-11

5. Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis;Cancer Medicine;2022-09-20